TP53 and cervical carcinoma: For example, ISG15 is increased in the cervical cancer context, and ISG15 depletion inhibits proliferation and migration, suggesting its pro-tumor role [82]; however, ISG15 also displays antitumor activities in cervical cancer cells but in a p53-dependent manner [83].